Development of a cytomegalovirus vector for somatic gene therapy

Area of Science:

• Molecular Biology
• Gene Therapy
• Virology

Background:

• Gene therapy requires efficient and targeted vector systems.
• Human cytomegalovirus (CMV) possesses tropism for hematopoietic progenitor cells and a large genome capacity, making it a potential candidate for gene transfer into these cells.
• Previous work involved cloning the CMV genome as a bacterial artificial chromosome (BAC) and establishing mutagenesis procedures.

Purpose of the Study:

• To construct a recombinant virus for evaluating CMV tropism.
• To monitor gene transfer into target cells using the recombinant virus.
• To assess CMV's cloning capacity and develop replication-deficient vectors for gene therapy.

Main Methods:

• Cloning of the CMV genome as a bacterial artificial chromosome (BAC).
• Establishment of mutagenesis procedures for CMV.
• Construction of a recombinant virus expressing Green Fluorescent Protein (GFP).

Main Results:

• A recombinant GFP-expressing CMV virus was successfully constructed.
• This virus will be utilized to re-evaluate CMV tropism.
• The study sets the stage for monitoring gene transfer and further vector development.

Conclusions:

• CMV is a promising candidate for gene therapy vectors targeting hematopoietic cells.
• The developed recombinant virus is a crucial tool for advancing CMV-based gene therapy.
• Future research will focus on evaluating cloning capacity and creating replication-deficient CMV vectors.